Shares of Moderna jumped 6.31% to $104.78 at 10:06 EST on Wednesday, after three successive sessions in a row of gains. The Nasdaq Stock Market is rising 1.31% to $12,036.80, after two sequential sessions in a row of gains, on what so far seems, an all-around positive trend trading session today.
Moderna’s last close was $101.03, 1.53% under its 52-week high of $103.20.
Moderna’s sales growth is 1195.8% for the current quarter and 5174.8% for the next. The company’s growth estimates for the current quarter is a negative 67.6% and positive 254.3% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $104.78 at 10:06 EST, above its 52-week high of $103.20.
Moderna’s worth is way higher than its 50-day moving average of $77.03 and way higher than its 200-day moving average of $69.89.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”